AMPHIVENA THERAPEUTICS
Amphivena Therapeutics is a clinical-stage immuno-oncology company that develops a platform of dual-function biologics. Its Amphivena ReSTORE platform provides dual-action biologics that relieve immune suppression and activate T cell effector function in cancer patients. The platform design integrates elements of avidity, target selectivity, and enhanced safety within a single molecule. It is also can be engineered with additional solid tumor targeting modalities to add functionality such as directed tumor cell killing. It was founded in 2012 and is headquartered in South San Francisco, California.
AMPHIVENA THERAPEUTICS
Social Links:
Industry:
Biotechnology Health Care Therapeutics
Founded:
2012-01-01
Address:
South San Francisco, California, United States
Country:
United States
Website Url:
http://www.amphivena.com
Total Employee:
11+
Status:
Active
Contact:
415-994-6455
Email Addresses:
[email protected]
Total Funding:
135.69 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics Apple Mobile Web Clips Icon WordPress Font Awesome Wordpress Plugins
Similar Organizations
Aimmune Therapeutics
Aimmune Therapeutics is a clinical-stage biopharmaceutical company that improves the lives of people with food allergies.
Cedilla Therapeutics
Cedilla Therapeutics is a biotechnology company that develops targeted small molecules for the treatment of cancer and other diseases.
Harpoon Therapeutics
Harpoon Therapeutics is a clinical-stage immunotherapy company developing novel T cell engagers (TriTACs) for the treatment of cancer.
Nivalis Therapeutics
Nivalis Therapeutics is a clinical-stage pharmaceutical company developing a novel class of disease modifying therapies.
Nutcracker Therapeutics
Nutcracker Therapeutics is a biotech company that develops mRNA therapeutics.
X4 Pharmaceuticals
X4 Pharmaceuticals a clinical-stage oncology company developing best-in-class oral small molecule CXCR4 antagonists for the treatment.
Current Advisors List
Current Employees Featured
Founder
Investors List
Qiming Venture Partners
Qiming Venture Partners investment in Series C - Amphivena Therapeutics
NanoDimension
NanoDimension investment in Series C - Amphivena Therapeutics
Industrial Investors Group
Industrial Investors Group investment in Series C - Amphivena Therapeutics
Solasta Ventures
Solasta Ventures investment in Series C - Amphivena Therapeutics
Clough Capital Partners
Clough Capital Partners investment in Series C - Amphivena Therapeutics
Franklin Berger
Franklin Berger investment in Series C - Amphivena Therapeutics
Newton Investment Management
Newton Investment Management investment in Series C - Amphivena Therapeutics
Merieux Developpement
Merieux Developpement investment in Series C - Amphivena Therapeutics
Aju IB Investment
Aju IB Investment investment in Series C - Amphivena Therapeutics
MPM Capital
MPM Capital investment in Series C - Amphivena Therapeutics
Key Employee Changes
| Date | New article |
|---|---|
| 2019-12-02 | Amphivena Therapeutics appoints president and CEO |
Official Site Inspections
http://www.amphivena.com
- Host name: 104.21.43.46
- IP address: 104.21.43.46
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
